1. Home
  2. DCO vs NRIX Comparison

DCO vs NRIX Comparison

Compare DCO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$137.98

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.68

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
NRIX
Founded
1849
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
DCO
NRIX
Price
$137.98
$16.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
$153.60
$30.50
AVG Volume (30 Days)
162.7K
793.6K
Earning Date
05-12-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,730,000.00
$76,987,000.00
Revenue This Year
$7.40
N/A
Revenue Next Year
$8.59
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
4.85
99.31
52 Week Low
$66.24
$8.20
52 Week High
$148.82
$22.50

Technical Indicators

Market Signals
Indicator
DCO
NRIX
Relative Strength Index (RSI) 49.80 52.12
Support Level $135.26 $16.02
Resistance Level $143.08 $16.71
Average True Range (ATR) 6.07 0.73
MACD -0.91 -0.06
Stochastic Oscillator 33.88 46.38

Price Performance

Historical Comparison
DCO
NRIX

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: